These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2855612)

  • 1. Synergy studies of ciprofloxacin and other quinolone derivatives in combination with further antibiotics.
    Höffler U
    Chemioterapia; 1987 Jun; 6(2 Suppl):140-2. PubMed ID: 2855612
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ciprofloxacin.
    Ferrara A; Donnetta A; Grassi FA; Gialdroni Grassi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):130-1. PubMed ID: 3151333
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergy of fluoroquinolones with other antimicrobial agents.
    Neu HC
    Rev Infect Dis; 1989; 11 Suppl 5():S1025-35. PubMed ID: 2505355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin in vitro activity alone and in combination against clinical isolates of glucose nonfermenting bacteria.
    Marklein G; Lotze G; Ungerechts J
    J Chemother; 1989 Jul; 1(4 Suppl):156-9. PubMed ID: 16312350
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex.
    Adepoju-Bello AA; Coker HA; Eboka CJ; Abioye AO; Ayoola GA
    Nig Q J Hosp Med; 2008; 18(3):133-6. PubMed ID: 19062475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial agents responsible for urinary tract infections. III. A clinico-statistical contribution].
    Roscioni C; Pennelli GM; Monaco G; Roscioni MC
    Clin Ter; 1988 Aug; 126(3):207-15. PubMed ID: 2974387
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Solak S; Willke A; Ergönül O; Tekeli E
    Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
    Yamada S; Hyo Y; Ohmori S; Ohuchi M
    Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial-agent sensitivity of bacteria isolated from dogs and cats.
    Hogle RM
    J Am Vet Med Assoc; 1970 Mar; 156(6):761-4. PubMed ID: 4192264
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.
    Jonas D; Biehler K; Hartung D; Spitzmüller B; Daschner FD
    Antimicrob Agents Chemother; 2005 Feb; 49(2):773-5. PubMed ID: 15673764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ciprofloxacin in combination with other antimicrobial substances].
    Shah PM; Mellinghoff D; Stille W
    Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.